White Paper Series: Effects of COVID-19 on the Healthcare Ecosystem — The Write Track, Inc.
Michael D. Dalzell/Editing Samples
In part 1 of this series, the authors recount how the COVID-19 pandemic has revealed vulnerabilities in the U.S. healthcare system. Just as the Great Depression, the OPEC oil embargo, and September 11 led to changes that had a lasting impact on society, the coronavirus crisis will, too. As we emerge from this crisis, an evolution is inevitable.
READ PART 1 ON THE COEUS CONSULTING GROUP WEBSITE
Because patients understand their journey in a way no one else does, what’s best for the patient should drive efforts among healthcare stakeholders to collaborate on priorities. In part 2 of this series, the authors describe the steps, cooperation, and capabilities that will be required to achieve a patient-focused, evidence-based system built around shared value.
READ PART 2 ON THE COEUS CONSULTING GROUP WEBSITE
COVID-19: Shaping the Next Normal in the Pharma Ecosystem
6/1/20
THE CHALLENGE:
Some of the lessons of the COVID-19 pandemic will not be known for years, but one thing was abundantly clear at an early stage: The U.S. healthcare system is not set up to tolerate major disruption. The crisis exposed shortcomings in readiness and misaligned priorities among stakeholders. “Business as usual” will never be the same. I helped the authors of this series of white papers to articulate the teachable moment and their vision of how providers, payers, and pharmaceutical companies can rethink relationships to improve delivery of patient-focused
